Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 2:30 pm Unchanged | 2023-12-31 | 13G | OncoSec Medical Incorporated ONCS | SZOP Multistrat LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-05-25 4:13 pm Purchase | 2023-05-16 | 13G | OncoSec Medical Incorporated ONCS | Mitchell P. Kopin | 313,158 4.990% | 313,158 (New Position) | Filing History |
| 2023-05-19 2:57 pm Purchase | 2023-05-16 | 13G | OncoSec Medical Incorporated ONCS | SZOP Opportunities I LLC | 257,118 5.650% | 257,118 (New Position) | Filing History |
| 2023-04-17 4:01 pm Purchase | 2023-04-13 | 13G | OncoSec Medical Incorporated ONCS | Lind Global Fund II LP | 460,733 9.900% | 460,733 (New Position) | Filing History |
| 2023-02-14 12:50 pm Unchanged | 2022-12-31 | 13G | OncoSec Medical Incorporated ONCS | Avidity Partners Management LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2022-02-11 8:34 pm Purchase | 2021-12-31 | 13G | OncoSec Medical Incorporated ONCS | Avidity Partners Management LP | 133,864 7.500% | 45,136 (+50.87%) | Filing History |